SMAD7 and colorectal carcinoma: Fortini et al. reported that the associated CRC risk at 18q21.1 was due to four SNPs including novel 1 (rs6507874, rs6507875, rs8085824, and rs58920878) in an enhancer affecting the expression of SMAD7 [22].